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Summary.-Thirteen biochemical parameters (viz. glucose, calcium, inorganic
phosphorus, urea nitrogen, uric acid, cholesterol, albumin, total protein, total
bilirubin, alkaline phosphatase, lactate dehydrogenase, aspartate aminotransferase,
and alanine aminotransferase) were determined in serum and partly in liver of rats
1-28 days after i.p. aflatoxin B1 (AFB) (3 mg/kg). Histological examinations of the
liver were also made in parallel to the biochemical studies. In the serum, enzyme
activities and total bilirubin level increased and peaked on the 2nd day, while other
parameters showed diverse changes after AFB treatment. On the other hand,
activities of aspartate aminotransferase and alanine aminotransferase in the liver
significantly decreased and reached a minimum on the 2nd day after AFB adminis-
tration. The depression of the liver enzyme activities persisted over 7 days. The liver
protein content also reduced transiently during 1-1-5 days. However, all biochemical
parameters returned to normal levels 2 weeks after treatment, and remained so
throughout the rest of experimental period. Histological changes in the liver were
very similar to those reported by others.
AFLATOXIN B1 (AFB)-a metabolite of
the mould Aspergillus flavus is the most
potent liver carcinogen known for the rat
(Wogan & Newberne, 1967) and has been
suspected of being a primary cause of
human liver cancer in certain areas,
particularly in Africa (Wogan, 1974;
Peers et al., 1976). The metabolism and
the biochemical effects of AFB are well
documented and reviewed (Wogan, 1968,
1969, 1973; Campbell & Hayes, 1976). A
major AFB-nucleic acid adduct has been
identified recently in vitro and in vivo
(Essigmann et al., 1977; Martin & Garner,
1977; Lin et al., 1977; Croy et al., 1978).
Furthermore, histological studies on the
sequential alterations produced by AFB
(Butler, 1964) andfluorescence microscopic
studies on the cellular localization of this
carcinogen (Stora et al., 1979; Stora, 1980)
have been reported. However, the AFB-
induced liver biochemical changes re-
ported previously were confined to the
initial fewv days of the acute injury stage
(Shank & Wogan, 1966; Svoboda et al.,
1966; Clifford & Rees, 1967). Since avail-
able information does not establish the
correlation between sequential biochemical
and histological changes in rats treated
with AFB, we have undertaken an inves-
tigation of the sequential effects of the
toxin on the biochemical parameters in
the serum and the biochemical and histo-
logical characters in the liver of rats for a
period of 28 days after a single dose.
MATERIALS AND METHODS
Animal and tissue preparation.-Male
Sprague-Dawley rats, weighing 100-120 g,
were used in the experiment. Animals were
fed on the "chick diet" containing about 20%
protein (supplied by Taiwan Sugar Corp.,
Taipei) without restriction. AFB dissolved in
dimethylformamide (3 mg/ml) was adminis-
tered i.p. at a dose of 3 mg/kg body wt. We
adopted this dose in the present study toS.-J. YIN, M.-C. KAO AND S.-C. LEE
reduce animal loss and toxin waste, because
our preliminary experiments indicated that if
the dose was increased from 3 to 4 mg/kg, the
mortality increased within 7 days after treat-
ment from 12% (of 92 rats) to 58% (of 151
rats). Most of the death occurred 1-3 days
after AFB administration, and rarely after 7
days. Control animals received an equal
volume of solvent, dimethylformamide, and
both groups ofanimals were maintained under
identical conditions throughout the period of
the experiment.
Overnight-fast animals were killed under
ether anaesthesia at the indicated intervals
after AFB administration, and the blood
samples were collected by cardiac puncture.
The liver was quickly removed and prepared
as a 20% homogenate in 0-25M sucrose solu-
tion with a Potter-Elvehjem tissue grinder
with a teflon pestle. The homogenate was
then centrifuged at 45,000 g for 60 min at
2°C, and the upper lipid layer was removed
by aspiration. The clear supernatant (post-
mitochondrial fraction) was used for various
enzyme determinations. Serum samples were
obtained by centrifuging at 2,600 g for 15 min
after the blood had clotted at room tempera-
ture for 1 h. Both the prepared sera and liver
samples were kept in an ice bath and assayed
within 12 h.
Chemicals.-Aflatoxin B1 was purchased
from Makor Chemicals Ltd, Jerusalem,
Israel. DL-Aspartic acid and DL-alanine
werefrom British DrugHouses, Poole, Dorset.
a-Ketoglutarate, 2,4-dinitrophenylhydrazine,
and p-nitrophenyl phosphate were from E.
Merck, Darmstadt, Germany. Fast Red
PDC, dimethylformamide, sodium DL-lactate
and NAD were from Sigma, St Louis, Mo.,
U.S.A. Bilirubin, p-nitrophenol and bovine
serum albumin were from Calbiochem, San
Diego, Calif., U.S.A. All reagents for the
SMA 12/60 Autoanalyzer were supplied by
Technicon Instruments Corp., Tarrytown,
N.Y., U.S.A.
Determinations.-Serum andliveraspartate
aminotransferase (AST) and alanine amino-
transferase (ALT) were assayed by the
method of Reitman & Frankel modified by
King (1965), and totalbilirubin (T. Bili) bythe
method ofMorin (1973), alkaline phosphatase
(ALP) by the method described by Bowers &
McComb (1975). Lactate dehydrogenase
(LDH) was determined by the method de-
scribed by King (1965) with a change of
temperature from 25°C to 30°C in our assay.
All enzyme activities determined in this study
were expressed in units. One unit (U) of
enzyme is defined as the amount that
catalyses the transformation of 1 ymol of
substrate/min under the described assay con-
ditions. Protein contents in sera and liver
homogenates were determined by the Lowry
method using bovine serum albumin as a
standard. Serumalbumin, glucose, cholesterol,
calcium, inorganic phosphorus, urea nitrogen
and uric acid were determined by Technicon
SMA 12/60 Autoanalyzer as previously
described (Lee et at., 1977).
Histology.-A piece of liver from each
animal used for biochemical determinations
was fixed in neutral 10% formalin, embedded
in paraffin, sectioned at 5-7 um and stained
with haematoxylin and eosin.
RESULTS
Body weight
The body weight of AFB-treated rats
decreased and reached a minimum on the
2ndday (weight loss about 14gperanimal),
then gradually increased thereafter. How-
ever, the growth rate was slightly lower
than that of control animals and the body
weight never reached that of control
animals throughout the rest of experi-
mental period (Fig. 1).
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FIG. 1.- Body-weight changes in rats after a
single dose of AFB given i.p. at 3 mg/kg.
Rats were killed at various intervals up
to 28 days. Control animals (0) received
dimethylformamide alone. AFB-treated
groups (0). Each point represents the
mean of at least 8 animals.
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TABLE I.-Changes in serum and liver proteins after AFB treatment
Serum protein
, A~~~~
Control Treated
(g/dl)
8-00+ 0 09 7.40+0-10***
7-89 + 0-32 7-26 + 0-22
7-93+0-11 7-63+0-16
7-91 + 0-17 7-42 + 0-22
7-54+0-11 6-93+0.09***
7 90 + 0-18 6-86 + 033*
7 90+0-11 6-97+0.19***
7-94 + 0-21 7-43 + 0-23
7-67 + 0-17 8-04+ 0-10
7-91 + 0-17 7 40+ 0-13
7-83+0-19 7-65+0-18
Liver protein
Control Treated
(mg/g wet wt)
235-4 + 4-5 199-0 + 93**
223-4 + 9-7 194-2 + 3-8**
236-4 + 8-1 233-2 + 4-1
237-8 + 6-0 224-7 + 7 0
221-9 + 4-4 215-0+ 6-3
232-0 + 6-6 216-7 + 6-2
220-4 + 3-1 216-1 + 7-9
230-3 + 4-9 227-0 + 4-7
240-1+5-4 228-7+7-7
254-7+4-6 240-8+8-5
241-9 + 6-1 929-2 + 7-2
Rats were given i.p. AFB (3 mg/kg) and killed at various times. Control groups received dimethyl-
formamide alone. The values are the means + s.e. of 6-8 animals. Statistical significances are expressed as
follows: * P < 005, ** P<0-01, or *** P < 0-001 when compared to control animals.
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FIG. 2. Biochemical changesinrat serum after
a single i.p. dose of AFB, at 3 mg/kg. Rats
were then killed atvarious intervals. Control
animals received dimethylformamide alone.
The enzyme activities are expressed as
mU/ml of serum, and T. Bili. as mg/dl
of serum. Vertical bars represent the
standard error of the ratios of AFB-treated
group to control group, with 6-8 animals for
each group.
Biochemical findings
Protein.-Changes in the serum and
liver protein content after AFB treatment
are shown in Table I. The liver protein
level was significantly reduced at 1-15
day, whilst interestingly serum protein
showed biphasic changes, significantly
decreasing on Day 1 and again during the
4-7 days after AFB administration. The
serum and liver protein contents, however,
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FiG. 3. Biochemical changes in rat liver after
a single i.p. dose of AFB (3 mg/kg). Rats
were then killed at various intervals. Con-
trol animals received dimethylformamide
alone. The enzyme activities are expressed
as CJ/g liver protein. Vertical bars represent
the s.e. of the ratios of AFB-treated group
to control group, with 6-8animalspergroup.
did not show any significant change during
the rest of the experiment.
Bilirubin and aminotransferases.-The
serum ALT and AST activities and T.
Bili. level all significantly increased and
peaked on the 2nd day (Fig. 2) while liver
ALT and AST activities significantly
decreased, reaching a minimum on the 2nd
day after AFB treatment (Fig. 3). The
depression of liver enzyme activities per-
Time after
dose
(days)
1
1-5
2
3
4
5
7
10
14
21
28
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TABLE II.-Activities of serum and liver ALP and LDH after AFB treatment
Serum Liver
ALP
Control Treated
(mU/ml)
204+6 284+11**
211+ 12 501 + 33**
214+ 4 336+ 22**
214+ 15 247+ 13*
212 + 8 238 + 10*
206+9 216+ 11
LDH
Control Treated
(mU/ml)
285+ 17 663+ 76**
283+ 20 971+ 144**
280+49 271+22
288+ 46 285+ 74
290+ 28 288 + 21
295+ 30 289+ 26
ALP
Control Treated
(mU/g protein)
594+ 30 585+ 28
676+ 33 663+ 61
620+29 612+27
586+ 39 586+ 20
659+ 56 642+ 36
653+ 46 630+ 19
LDH
Control Treated
(U/g protein)
926+ 93 868+ 55
924+ 35 980+ 54
859+ 96 868+ 33
826+ 75 794+ 40
826 + 23 802+ 39
810+ 30 829+ 33
Rats were given i.p. AFB (3 mg/kg) and killed at various times. Control groups received dimethylformamide
alone. The values are the means + s.e. of 6-8 animals. * P < 0 05, or ** P < 0-001 wlhen compared to control
animals.
sisted over 7 days. The ALT activity was
still 15% depressed on the 10th day, but
all enzyme activities completely recovered
by Day 14. Changes in the activities of
these 2 liver enzymes were parallel,
though a greater extent of alteration wvas
seen in ALT.
Alkalinephosphatase and lactate dehydro-
genase. Serum ALP and LDH activities
of the AFB-treated rats significantly
increased and peaked on the 2nd day,
at 343 and 237% of control groups, respec-
tively, and then decreased gradually (ALP
much more slowly than LDH) (Table II).
By contrast, no significant change was
seen for liver ALP and LDH over 10 days
from dosing (Table II).
Other serum biochemical parameters.
Alterations ofserum, inorganicphosphorus,
glucose, cholesterol andalbumin are shown
in Table III. Serum albumin and inorganic
phosphorus decreased on Days 4-7 and
1-2, respectively, whereas glucose and
cholesterol increased on Days 1 and 3,
respectively. Other serum biochemical
parameters including calcium, urea nitro-
gen and uric acid, did not significantly
change.
Histological findings. In general, liver-
cell necrosis appeared 36-48 h after AFB
poisoning, and the periportal zone of
necrosis was replaced by histiocytes 3 days
later. On the 3rd day, biliary prolifera-
tion extended into the zone of necrosis
and persisted through the remainder ofthe
period. Hepatocellular regeneration was
very slow, and the parenchymal cells
showed hyperchromatic and irregular-
sized nuclei, especially obvious on the
28th day. These findings are in good agree-
ment with those described by Butler
(1964).
DISCUSSION
AFB is known as a potent inhibitor on
DNA and RNA synthesis in vivo and in
vitro (Wogan, 1968, 1969; Akinrimisi et al.,
1974; Yu, 1977). However, studies of
AFB action on protein synthesis and pro-
tein content in the rat liver have yielded
contradictory results (Clifford & Rees,
1967; Shank & Wogan, 1966; Villa-
Trevino & Leaver, 1968; Ramachandra
Pai et al., 1978). In concerning the effect
of AFB on liver protein content, some
reported no significant effect (Shank &
Wogan, 1966) but Ramachandra Pai et al.
(1978) showed a significant decrease on
Day 1 after dosing. In the present study,
a transient but significant reduction (10-
15%) of liver protein content occurred on
Day 1-] 5 after AFB treatment (Table I);
moreover, the serum protein level de-
creased significantly on Day 1 and during
4-7 days after dosing (Table I). The serum
albumin also showed a fall at 4-7 days
(Table III). These results indicate that
AFB has a transient but significant effect
in lowering serum and liver protein con-
tents in the rat.
The present study showed that the
activities of serum ALT, AST, LDH and
Time
after
(dose
(days)
1
2
3
5
7
10
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ALP, and T. Bili. increasedgreatly on the
2nd day, but the liver ALT and AST
activities fell to a minimum on the 2nd
day and remained low over 7 days after
AFB treatment (Figs. 2, 3; Table 11). A
complete recovery of the liver ALT
activity had occurred 2 ,i-eeks later. The
patterns ofchange for serum ALP activity
and bilirubin content found in the present
study were different from those reported
by Clifford & Rees (1967). The latter
found that these 2 serum parameters
remained nearly unchanged for the first 3
days, but rose sharply on Day 4 after
AFB treatment (LD50 dose by gastric
intubation). These disagreements may be
due to the differences in the rat strain,
dosage, and the route of administration.
Interestingly, in Clifford & Rees' Report
(1967) activities of serum isoeitrate de-
hydrogenase, malate dehydrogenase and
glutamate dehydrogenase, not determined
in our studies, changed over the first 4
days after AFB administration, in a way
similar to that of serum ALT, AST, LDH
and ALP in the present study, although
this similarity was not found in the liver
enzyme activities.
Rees & Sinha (1960) reported that rat
serum isocitrate dehydrogenase, malate
dehydrogenase, glutamate dehvdrotienase
and AST activities peaked on Day I after
poisoning with CC14 (1-25 ml/kg, gastric
intubation) or with thioacetamide (200
mg/kg i.p.) for a 4-day experiment. How-
ever, in our comparative 4-week study in
rats poisoned by CC14 (0-5 ml/kg i.p.) it
was shown that serum ALT and AST
activities were markedly high and both
peaked on Day 1-5 after administration
(to be published elsewhere). The activities
of ALT and AST in the serum of our
CC14-treated rats 1-5 days after dosing
were 13-7 and 7.2 times the control level,
respectively, magnitudes similar to those
found in the AFB-treated rats (Fig. 2).
However , no significant reduction of ALT
and AST activities in the liver was seen in
our CC14-treated rats. Furthermore, the
loss of body weight for the experimental
rats was minimal for the first 4 days after
CC14 treatment, aiid the body weight
quickly caught up with the control
animals thereafter. It, seems, therefore,
that serurn enzyme alterations in toxic
liver damage mi-yht, vary with rat strain,
age and sex Of the rat, dose of toxin, and
even route of administration, other than
the modes of action of different. toxins.
AFB is a relatively specific hepato-toxic
agent (Butler, 1964; Clifford & Rees,
1967; Wogan, 1969, 1973). Serum bio-
chemical parameters including the con-
centrations of blood urea nitrooren (BUN),
uric acid, and calcium showed no appre-
ciable change during the experiment.
Although seriim inorganic phosphorus,
glucose and cholesterol changed tran-
siently during the first, 3 days, their
changes were slight. These observations
provide additional information on the
specificity of liver toxicity by AFB.
Wogan & Friedman (1968) showed aii
inhibition of cortisol induction on liver
tryptophan pyrrolase and tyrosine amino-
transferase for a period of more than 10
days in rats treated with AFB. Their
observation, alono, with the persistent
depression ofliver ALT and AST activities
for 7 days after AFB as seen in the present
study (Fig. 3), indicate that AFB has a
rather long-lasting toxic effect on the liver
tissue, although AFB has been shoivn to be
rapidly absorbed, metabolized and re-
moved by the rat liver (Wogan et al.,
1967; Wogan, 1969; Unger et al., 1977;
1977). Such prolonged liver Swenson et al., ?I
toxicity ofAFB might be due to weak but
persistent liver injury which can not be
completely compensated for by slow
hepatic regeneration.
The histological findings that periportal
necrosis appeared on Day I and was
maximal 1-5-2 days after AFB treatment
correlated well with the biochemical
findings of a sharp augmentation of the
activities of serum ALT, AST, LDH and
ALP during the 1-2 days after dosing. It
appeared that the histological and bio-
chemical data from rats treated with AFB
in the present study were chronologically
correlated.SEQUENTIAL ALTERATIONS AND AFLATOXIN Bi 325
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